<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Park Medical Centre</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to: identify unusual prescribing, collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>The below reports have been developed to use “z-scores” to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. It is important to remember that
            this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where it might not. Our full analytical
            method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a> but briefly we calculate the number of prescriptions for each chemical in the BNF coding system using the BNF subparagraph as a denominator.
            We used the time period from April 2021 to August 2021. We then calculate the mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs. From this we can calculate the “z-score”, which is a measure
            of how many standard deviations a given practice/CCG/PCN is from the population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier
            for prescribing lower than its peers.</p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=+">survey</a>            or emailing us at
            <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can send short or detailed
            feedback.
        </p>
        <h2>Prescribing where The Park Medical Centre is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=1310020J0&amp;denomIds=13.10.2&amp;selectedTab=summary">Econazole nitrate</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>2</td>
      <td>Antifungal preparations</td>
      <td>69</td>
      <td>0.03</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>24.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=1310020J0BCAAAA&amp;denomIds=13.10.2&amp;selectedTab=summary" target="_blank">Pevaryl 1% cream : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0404000W0&amp;denomIds=4.4&amp;selectedTab=summary">Pitolisant hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>CNS Stimulants and drugs used for ADHD</td>
      <td>135</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.67</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0404000W0AAAAAA&amp;denomIds=4.4&amp;selectedTab=summary" target="_blank">Pitolisant 18mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=1003020AE&amp;denomIds=10.3.2&amp;selectedTab=summary">Methyl salicylate/levomenthol</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>325</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>7.41</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=1003020AEAAAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Methyl salicylate 105mg/Levomenthol 31.5mg : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=1106000I0&amp;denomIds=11.6&amp;selectedTab=summary">Betaxolol</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>5</td>
      <td>Treatment of glaucoma</td>
      <td>196</td>
      <td>0.03</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>5.40</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=1106000I0AAAAAA&amp;denomIds=11.6&amp;selectedTab=summary" target="_blank">Betaxolol 0.5% eye drops : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0205051Z0&amp;denomIds=2.5.5&amp;selectedTab=summary">Perindopril arginine with diuretic</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>23</td>
      <td>Angiotensin-converting enzyme inhibitors</td>
      <td>1678</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>5.33</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0205051Z0AAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Perindopril arginine 5mg / Indapamide 1.25mg tablets : 23</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Park Medical Centre is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0106010E0&amp;denomIds=1.6.1&amp;selectedTab=summary">Ispaghula husk</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>46</td>
      <td>Bulk-forming laxatives</td>
      <td>73</td>
      <td>0.63</td>
      <td>0.96</td>
      <td>0.07</td>
      <td>-4.49</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0106010E0AAADAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Ispaghula husk 3.5g efferv gran sach gluten free sugar free : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0106010E0BBAAAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel 3.5g effervescent granules sachets plain SF : 14</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0106010E0BBABAD&amp;denomIds=1.6.1&amp;selectedTab=summary" target="_blank">Fybogel Orange 3.5g effervescent granules sachets SF : 18</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0403010B0&amp;denomIds=4.3.1&amp;selectedTab=summary">Amitriptyline hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>442</td>
      <td>Tricyclic and related antidepressant drugs</td>
      <td>737</td>
      <td>0.60</td>
      <td>0.84</td>
      <td>0.08</td>
      <td>-3.14</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0403010B0AAAGAG&amp;denomIds=4.3.1&amp;selectedTab=summary" target="_blank">Amitriptyline 10mg tablets : 218</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0403010B0AAAHAH&amp;denomIds=4.3.1&amp;selectedTab=summary" target="_blank">Amitriptyline 25mg tablets : 102</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0403010B0AAAIAI&amp;denomIds=4.3.1&amp;selectedTab=summary" target="_blank">Amitriptyline 50mg tablets : 122</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0601021M0&amp;denomIds=6.1.2&amp;selectedTab=summary">Gliclazide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>163</td>
      <td>Sulfonylureas</td>
      <td>322</td>
      <td>0.51</td>
      <td>0.92</td>
      <td>0.14</td>
      <td>-3.09</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0601021M0AAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 80mg tablets : 90</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0601021M0AAARAR&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 40mg tablets : 45</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0601021M0AAAMAM&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Gliclazide 30mg modified-release tablets : 28</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0202030S0&amp;denomIds=2.2.3&amp;selectedTab=summary">Spironolactone</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>94</td>
      <td>Potassium-sparing diuretics and aldosterone antagonists</td>
      <td>269</td>
      <td>0.35</td>
      <td>0.72</td>
      <td>0.14</td>
      <td>-2.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0202030S0AAATAT&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 25mg tablets : 61</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0202030S0AAAVAV&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 100mg tablets : 27</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0202030S0AAAUAU&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 50mg tablets : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=P84045&amp;numIds=0906011D0&amp;denomIds=9.6.1&amp;selectedTab=summary">Vitamin A</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>0</td>
      <td>Vitamin A</td>
      <td>6</td>
      <td>0.00</td>
      <td>0.84</td>
      <td>0.35</td>
      <td>-2.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>